Dexamethasone oral film
US11083734B2 · kind B2 · utility
0Cited by
0References
17Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | Dec 7, 2018 |
| Grant date | Aug 10, 2021 |
| Priority date | — |
| Expiry date | Apr 30, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to an oral film consisting essentially of dexamethasone and hydroxypropyl methylcellulose, wherein the concentration of dexamethasone is 30% w/w or more and the concentration of hydroxypropyl methylcellulose is between 35 and 70% w/w based on total dry matter.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.